0001437749-22-025966.txt : 20221104 0001437749-22-025966.hdr.sgml : 20221104 20221104124122 ACCESSION NUMBER: 0001437749-22-025966 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20221103 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221104 DATE AS OF CHANGE: 20221104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATIONAL HEALTHCARE CORP CENTRAL INDEX KEY: 0001047335 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SKILLED NURSING CARE FACILITIES [8051] IRS NUMBER: 522057472 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-13489 FILM NUMBER: 221361292 BUSINESS ADDRESS: STREET 1: 100 E. VINE ST CITY: MURFREESBORO STATE: TN ZIP: 37130 BUSINESS PHONE: 6158902020 MAIL ADDRESS: STREET 1: 100 E. VINE ST CITY: MURFREESBORO STATE: TN ZIP: 37130 8-K 1 nhc20221103_8k.htm FORM 8-K nhc20221103_8k.htm
false 0001047335 0001047335 2022-11-03 2022-11-03
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): November 4, 2022 (November 3, 2022)
 
 
NATIONAL HEALTHCARE CORPORATION
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
001-13489
52-2057472
(State or other jurisdiction of
incorporation)
 (Commission File Number) (I.R.S. Employer Identification No.)
100 E. Vine Street
Murfreesboro, Tennessee
  
37130
(Address of Principal Executive
Offices)
   (Zip Code)
 
Registrant’s telephone number, including area code: (615) 890-2020
 
Not Applicable
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Exchange Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, $.01 par value
NHC
NYSE American
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1988 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
ITEM 2.02.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION
 
National HealthCare Corporation (“NHC”) issued a press release on November 3, 2022, announcing its September 30, 2022 earnings. The entire press release is attached as Exhibit 99.1 and is incorporated by reference herein.
 
 
ITEM 8.01.
OTHER EVENTS.
 
NHC issued a press release on November 4, 2022, announcing its quarterly common dividend. The entire press release is attached as Exhibit 99.2 and is incorporated by reference herein.
 
 
ITEM 9.01.
FINANCIAL STATEMENTS AND EXHIBITS.
 
(d)         Exhibits.
 
Exhibit No.
Description of Exhibit
99.1
   
99.2 Copy of press release issued on November 4, 2022 by National HealthCare Corporation announcing quarterly common dividend.
   
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date:         November 4, 2022
 
  NATIONAL HEALTHCARE CORPORATION
     
  By: /s/ Brian F. Kidd
  Name: Brian F. Kidd
  Title:
Senior VP/Controller
Principal Accounting Officer
 
 
 EX-99.1 2 ex_442460.htm EXHIBIT 99.1 ex_442460.htm

Exhibit 99.1

 

pic1.jpg

 

 

For release: November 3, 2022

Contact: Brian F. Kidd, SVP/Controller

Phone: (615) 890-2020

 

 

NHC Reports Third Quarter 2022 Earnings

 

MURFREESBORO, Tenn. -- National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues and government stimulus income for the quarter ended September 30, 2022 totaled $270,843,000 compared to $276,737,000 for the quarter ended September 30, 2021, a decrease of 2.1%. The net operating revenues decrease during the third quarter of 2022 was primarily driven by the reduction in government stimulus income of $10.4 million during the third quarter of 2022 compared to the same period a year ago, as well as us exiting the seven skilled nursing facilities in Massachusetts and New Hampshire during the third quarter of 2022. Excluding the government stimulus income, same-facility net operating revenues increased 3.8% during the third quarter of 2022 compared to the same period a year ago.

For the quarter ended September 30, 2022, the reported GAAP net loss attributable to NHC was $2,429,000 compared to a net loss of $3,348,000 for the same period in 2021. Excluding the unrealized losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the quarter ended September 30, 2022 was $7,783,000 compared to $14,884,000 for the same period in 2021 (*). The decrease in non-GAAP earnings for the third quarter of 2022 compared to the same period in 2021 was primarily due to the $10.4 million less of government stimulus income recorded, as well as incurring inflationary wage pressures on our labor costs. GAAP diluted loss per share was $0.16 for the quarter ended September 30, 2022 compared to a diluted loss per share of $0.22 for the same period in 2021. Adjusted diluted earnings per share were $0.50 and $0.96 for the quarters ended September 30, 2022 and 2021, respectively (*).

 

(*) - See the tables below that provide a reconciliation of GAAP to non-GAAP items.

 

About NHC

NHC affiliates operate for themselves and third parties 68 skilled nursing facilities with 8,726 beds. NHC affiliates also operate 23 assisted living communities with 1,181 units, five independent living communities with 475 units, three behavioral health hospitals, 35 homecare agencies, and 29 hospice agencies. NHC’s other services include Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at www.nhccare.com.

 

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

 

Forward-Looking Statements

Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q and 10-K, and include, among others, the following: liabilities and other claims asserted against us and patient care liabilities, as well as the resolution of current litigation; availability of insurance and assets for indemnification; national and local economic conditions; including their effect on the availability and cost of labor, utilities and materials; the effect of government regulations and changes in regulations governing the healthcare industry, including our compliance with such regulations; changes in Medicare and Medicaid payment levels and methodologies and the application of such methodologies by the government and its fiscal intermediaries; and other factors referenced or incorporated by reference in the S.E.C. filings. The risks included here are not exhaustive. All forward-looking statements represent NHC’s best judgment as of the date of this release.

-more-

 

 
 

 

Page 2

 

Consolidated Statements of Operations

(in thousands, except share and per share amounts)

 

   

Three Months Ended

    

Nine Months Ended

  
   

September 30

    

September 30

  
   

2022

    

2021

    

2022

    

2021

  
   

(unaudited)

    

(unaudited)

  

Revenues and grant income:

                                

Net patient revenues

   $ 260,247     $ 254,817     $ 776,661     $ 708,648  

Other revenues

     10,596       11,491       33,584       33,916  

Government stimulus income

     -       10,429       10,940       48,304  

Net operating revenues and grant income

     270,843       276,737       821,185       790,868  
                                 

Costs and expenses:

                                

Salaries, wages and benefits

     173,198       170,235       518,828       483,263  

Other operating

     72,883       73,109       218,279       204,211  

Facility rent

     10,294       10,204       30,770       30,437  

Depreciation and amortization

     10,253       10,229       30,011       30,521  

Interest

     137       198       451       657  

Total costs and expenses

     266,765       263,975       798,339       749,089  
                                 

Income from operations

     4,078       12,762       22,846       41,779  
                                 

Non-operating income

     2,731       3,399       8,451       15,245  

Gain on acquisition of equity method investment

     -       -       -       95,202  

Unrealized losses on marketable equity securities

     (11,056 )     (23,797 )     (11,479 )     (23,227 )
                                 

Income/(loss) before income taxes

     (4,247 )     (7,636 )     19,818       128,999  

Income tax (provision)/benefit

     1,140       4,090       (5,415 )     (5,907 )

Net income/(loss)

     (3,107 )     (3,546 )     14,403       123,092  
                                 

Net (income)/loss attributable to noncontrolling interest

     678       198       1,689       (290 )
                                 

Net income/(loss) attributable to National HealthCare Corporation

   $ (2,429 )   $ (3,348 )   $ 16,092     $ 122,802  
                                 

Net income/(loss) per common share

                                

Basic

   $ (0.16 )   $ (0.22 )   $ 1.04     $ 8.00  

Diluted

   $ (0.16 )   $ (0.22 )   $ 1.04     $ 7.97  
                                 

Weighted average common shares outstanding

                                

Basic

     15,445,569       15,364,043       15,438,375       15,347,042  

Diluted

     15,445,569       15,364,043       14,577,103       15,414,683  
                                 

Dividends declared per common share

   $ 0.57     $ 0.52     $ 1.69     $ 1.56  

 

 

Balance Sheet Data

    Sept. 30     Dec. 31  

(in thousands)

  

2022

    

2021

  
   

(unaudited)

          
                 

Cash, cash equivalents and marketable securities

   $ 176,729     $ 256,025  

Restricted cash, cash equivalents and marketable securities

     171,898       175,884  

Current assets

     344,529       426,638  

Property and equipment, net

     511,373       520,996  

Total assets

     1,295,559       1,403,396  

Current liabilities

     210,156       263,201  

NHC stockholders' equity

     877,311       903,004  

  

-more-

 

 
 

 

Page 3

 

Selected Operating Statistics

   

Three Months Ended

    

Nine Months Ended

  
   

September 30

    

September 30

  
   

2022

    

2021

    

2022

    

2021

  
   

(unaudited)

    

(unaudited)

  

Skilled Nursing Per Diems:

                                

Medicare

   $ 535.60     $ 523.98     $ 540.30     $ 528.60  

Managed Care

     429.22       404.43       425.39       406.32  

Medicaid

     237.61       231.39       230.79       225.68  

Private Pay and Other

     265.68       257.13       268.13       254.03  
                                 

Average Skilled Nursing Per Diem

   $ 302.43     $ 295.40     $ 301.91     $ 297.04  
                                 

Skilled Nursing Patient Days:

                                

Medicare

     81,940       87,534       258,961       271,024  

Managed Care

     52,956       57,486       163,823       183,593  

Medicaid

     302,500       315,979       919,931       895,955  

Private Pay and Other

     169,068       158,011       489,477       439,225  
                                 

Total Skilled Nursing Patient Days

     606,464       619,010       1,832,192       1,789,797  

 

 

The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts):

 

   

Three Months Ended

    

Nine Months Ended

  
   

September 30

    

September 30

  
   

2022

    

2021

    

2022

    

2021

  
   

(unaudited)

    

(unaudited)

  
                                 

Net income/(loss) attributable to National Healthcare Corporation

   $ (2,429 )   $ (3,348 )   $ 16,092     $ 122,802  

Non-GAAP adjustments

                                

Unrealized losses on marketable equity securities

     11,056       23,797       11,479       23,227  

Operating results for newly opened facilities not at full capacity (1)

     2,105       115       4,033       480  

Gain on acquisition of equity method investment

     -       -       -       (95,202 )

Stock-based compensation expense

     639       726       1,980       1,905  

Income tax benefit on non-GAAP adjustments

     (3,588 )     (6,406 )     (4,548 )     (6,369 )

Non-GAAP Net income

   $ 7,783     $ 14,884     $ 29,036     $ 46,843  
                                 

GAAP diluted earnings/(loss) per share

   $ (0.16 )   $ (0.22 )   $ 1.04     $ 7.97  

Non-GAAP adjustments

                                

Unrealized losses on marketable equity securities

     0.53       1.14       0.56       1.12  

Operating results for newly opened facilities not at full capacity (1)

     0.10       0.01       0.19       0.02  

Gain on acquisition of equity method investment

     -       -       -       (6.16 )

Stock-based compensation expense

     0.03       0.03       0.09       0.09  

Non-GAAP diluted earnings per share

   $ 0.50     $ 0.96     $ 1.88     $ 3.04  

 

(1) The newly opened facilities not at full capacity for the 2022 period presented consisted of operations opened from 2020 through 2022. This consisted of two behavioral health hospitals, one homecare agency, and one hospice agency. The newly opened facilities for the 2021 period presented consisted of operations opened from 2019 through 2021. The 2021 period consisted of one memory care facility.

 

 

###

 

 
 EX-99.2 3 ex_442466.htm EXHIBIT 99.2 ex_442466.htm

Exhibit 99.2

 

pic1.jpg

 

 

For release: November 4, 2022

Contact: Brian F. Kidd, SVP/Controller

Phone: (615) 890-2020

 

 

 

 

NHC Announces Common Dividend

 

MURFREESBORO, Tenn. -- National HealthCare Corporation (NYSE American: NHC), the nation’s oldest publicly traded long-term health care company, announced today that it will pay a quarterly dividend of 57 cents per common share to shareholders of record on December 30, 2022 and payable on February 1, 2023.

 

 

 

 

Forward-Looking Statements

 

Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q and 10-K, and include, among others, the following: liabilities and other claims asserted against us and patient care liabilities, as well as the resolution of current litigation; availability of insurance and assets for indemnification; national and local economic conditions; including their effect on the availability and cost of labor, utilities and materials; the effect of government regulations and changes in regulations governing the healthcare industry, including our compliance with such regulations; changes in Medicare and Medicaid payment levels and methodologies and the application of such methodologies by the government and its fiscal intermediaries, the ability of third parties for whom we have guaranteed debt to refinance certain short term debt obligations; and other factors referenced or incorporated by reference in the S.E.C. filings. The risks included here are not exhaustive. All forward-looking statements represent NHC’s best judgment as of the date of this release.

 

About NHC

 

NHC affiliates operate for themselves and third parties 68 skilled nursing facilities with 8,726 beds. NHC affiliates also operate 23 assisted living communities with 1,181 units, five independent living communities with 475 units, three behavioral health hospitals, 35 homecare agencies, and 29 hospice agencies. NHC’s other services include Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at www.nhccare.com.

 

 
 EX-101.SCH 4 nhc-20221103.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 5 nhc-20221103_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 6 nhc-20221103_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Trading Symbol Security Exchange Name Entity, Emerging Growth Company Amendment Flag Entity, Central Index Key EX-101.PRE 7 nhc-20221103_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 8 pic1.jpg begin 644 pic1.jpg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end XML 9 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document And Entity Information
Nov. 03, 2022
Document Information [Line Items]  
Entity, Registrant Name NATIONAL HEALTHCARE CORPORATION
Document, Type 8-K
Document, Period End Date Nov. 03, 2022
Entity, Incorporation, State or Country Code DE
Entity, File Number 001-13489
Entity, Tax Identification Number 52-2057472
Entity, Address, Address Line One 100 E. Vine Street
Entity, Address, City or Town Murfreesboro
Entity, Address, State or Province TN
Entity, Address, Postal Zip Code 37130
City Area Code 615
Local Phone Number 890-2020
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol NHC
Security Exchange Name NYSE
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0001047335
XML 10 nhc20221103_8k_htm.xml IDEA: XBRL DOCUMENT 0001047335 2022-11-03 2022-11-03 false 0001047335 8-K 2022-11-03 NATIONAL HEALTHCARE CORPORATION DE 001-13489 52-2057472 100 E. Vine Street Murfreesboro TN 37130 615 890-2020 false false false false Common Stock NHC NYSE false EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 1 22 1 false 0 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.nhc.com/20221103/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports nhc20221103_8k.htm ex_442460.htm ex_442466.htm nhc-20221103.xsd nhc-20221103_def.xml nhc-20221103_lab.xml nhc-20221103_pre.xml http://xbrl.sec.gov/dei/2021q4 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "nhc20221103_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "local": [ "nhc-20221103_def.xml" ] }, "inline": { "local": [ "nhc20221103_8k.htm" ] }, "labelLink": { "local": [ "nhc-20221103_lab.xml" ] }, "presentationLink": { "local": [ "nhc-20221103_pre.xml" ] }, "schema": { "local": [ "nhc-20221103.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 26, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "nhc", "nsuri": "http://www.nhc.com/20221103", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nhc20221103_8k.htm", "contextRef": "d20228K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://www.nhc.com/20221103/role/statement-document-and-entity-information", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "nhc20221103_8k.htm", "contextRef": "d20228K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document, Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document, Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity, Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity, Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity, Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity, Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity, Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity, Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity, File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity, Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity, Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity, Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.nhc.com/20221103/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 17 0001437749-22-025966-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-22-025966-xbrl.zip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end